Your browser doesn't support javascript.
loading
Effect of systemic bevacizumab in severe hereditary hemorrhagic telangiectasia associated with bleeding.
Epperla, Narendranath; Kapke, Jonathan T; Karafin, Matthew; Friedman, Kenneth D; Foy, Patrick.
Afiliação
  • Epperla N; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Kapke JT; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Karafin M; Division of Transfusion Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Friedman KD; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Foy P; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Am J Hematol ; 91(6): E313-4, 2016 06.
Article em En | MEDLINE | ID: mdl-26994402
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telangiectasia Hemorrágica Hereditária / Bevacizumab / Antineoplásicos Imunológicos / Hemorragia Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telangiectasia Hemorrágica Hereditária / Bevacizumab / Antineoplásicos Imunológicos / Hemorragia Idioma: En Ano de publicação: 2016 Tipo de documento: Article